V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320007124 | 320004228 | 1.61 | 67.4 | Palliative (P) | 2016-03-25 | 2016-05-07 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 320019034 | ECX |
| 320007125 | 320004232 | 1.71 | 103.3 | Adjuvant (A) | 2015-09-07 | 2016-01-29 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 320019154 | DOCETAXEL |
| 320007127 | 320004239 | 1.54 | 37.05 | Palliative (P) | 2016-08-12 | 2016-08-13 | CARBOPLATIN + FLUOROURACIL | Y | N | 320020239 | IPILIMUMAB |
| 320007128 | 320004246 | 1.8 | 88 | Disease modification (D) | 2018-01-25 | 2018-02-23 | Imatinib 600mg | N | N | 320021324 | CAPECITABINE |
| 320007129 | 320004248 | 1.76 | 65.8 | Palliative (P) | 2017-06-11 | 2017-11-16 | CETUXIMAB + RT | N | N | 320021327 | CISPLATIN + ETOPOSIDE |
| 320007130 | 320004250 | null | 105.4 | Palliative (P) | 2015-10-22 | 2016-09-30 | CNS Low Grade Glioma Vinblastine | N | N | 320021379 | TRASTUZUMAB |
| 320007131 | 320004254 | 1.57 | null | Palliative (P) | 2016-09-03 | 2016-09-25 | ICON8 TRIAL | 2 | null | 320021396 | DOCETAXEL |
| 320007132 | 320004256 | 1.53 | 79.3 | Curative (C) | 2015-09-28 | 2015-09-28 | EOX | 02 | N | 320021407 | CARBO + FLUOROURACIL |
| 320007133 | 320005953 | 1.73 | 67.6 | Palliative (P) | 2019-02-28 | 2019-05-02 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 320021426 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320007134 | 320004271 | 1.6 | 54.8 | Disease modification (D) | 2015-03-23 | 2015-05-01 | CISPLATIN + ETOPOSIDE | N | N | 320021777 | CARBOPLATIN + DOCETAXEL |
| 320007135 | 320004274 | 1.64 | 87 | Curative (C) | 2017-01-07 | 2017-01-14 | Ipilimumab | N | N | 320021893 | RUXOLITINIB |
| 320007136 | 320004276 | 1.75 | 67.3 | Palliative (P) | 2014-05-03 | 2014-05-04 | CETUXIMAB + OXALIPLATIN + MDG | N | N | 320021917 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320007137 | 320005961 | 1.58 | 97 | null | 2018-03-23 | 2018-04-26 | ICON8 TRIAL | N | N | 320022034 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320007138 | 320006765 | 1.86 | 87.6 | Palliative (P) | 2015-07-10 | 2015-07-11 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 320022127 | CARBOPLATIN + CETUXIMAB + FU |
| 320007139 | 320006766 | 1.7 | 69 | Palliative (P) | 2016-10-12 | 2016-10-22 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320022208 | IRINOTECAN + MDG |
| 320007140 | 320004280 | 1.74 | 61.5 | Adjuvant (A) | 2017-09-22 | 2017-09-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 320022352 | IVA |
| 320007141 | 320004286 | null | 65.7 | Disease modification (D) | 2018-11-03 | 2018-11-04 | Cetuximab + CISPLATIN + FLUOROURACIL | 2 | N | 320023759 | CAPECITABINE + CETUXIMAB + CISPLATIN |
| 320007142 | 320004297 | 1.7 | 87.85 | Palliative (P) | 2017-07-18 | 2017-08-18 | BEVACIZUMAB + CARBO + PACLITAXEL | N | null | 320007575 | RMS 2005 TRIAL |
| 320007143 | 320004299 | 1.72 | 35.8 | Neo-adjuvant (N) | 2019-04-12 | 2019-04-13 | NIVOLUMAB | Y | N | 320008094 | CETUXIMAB + RT |
| 320007144 | 320004301 | 1.53 | 65 | Curative (C) | 2019-04-22 | 2019-07-19 | CARBOPLATIN + RT | 02 | N | 320008329 | CAPECITABINE + CARBOPLATIN |
| 320007145 | 320004304 | 1.65 | 29.1 | Palliative (P) | 2015-08-29 | 2018-07-22 | Oxaliplatin + Modified de Gramont | 2 | N | 320008581 | DOCETAXEL |
| 320007146 | 320005977 | null | null | Palliative (P) | 2017-02-14 | 2017-03-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 320009033 | ATEZOLIZUMAB |
| 320007147 | 320004313 | 2 | null | null | null | 2018-12-04 | VAC | N | N | 320010225 | TEMOZOLOMIDE |
| 320007148 | 320004317 | 1.67 | 51 | Palliative (P) | 2018-04-26 | 2018-04-27 | Carboplatin + Docetaxel | 02 | N | 320012126 | FLUOROURACIL + MITOMYCIN + RT |
| 320007149 | 320004319 | 1.65 | 80 | Palliative (P) | 2019-09-17 | 2019-09-21 | CARBOPLATIN + RT | 2 | N | 320013061 | AFLIBERCEPT + FU + IRINOTECAN |
| 320007150 | 320004325 | 1.58 | 78 | Palliative (P) | 2017-12-27 | 2018-03-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | Y | N | 320021501 | VINCRISTINE |
| 320007151 | 320002684 | 1.62 | 81.9 | Palliative (P) | 2015-06-11 | 2015-06-11 | Carboplatin AUC 6 - 10 | N | N | 320001353 | CARBOPLATIN |
| 320007152 | 320002695 | 1.78 | 55.25 | Adjuvant (A) | 2017-01-12 | 2017-01-19 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 320002696 | CARBOPLATIN + PACLITAXEL |
| 320007153 | 320002699 | 1.63 | 76.4 | null | 2013-10-07 | 2013-10-17 | CARBOPLATIN | 02 | N | 320002703 | CARBOPLATIN |
| 320007154 | 320002709 | 1.79 | 65 | Palliative (P) | 2015-08-15 | 2015-09-11 | CARBOPLATIN + PACLITAXEL | 02 | N | 320002904 | CARBOPLATIN + PACLITAXEL |
| 320007155 | 320002716 | 1.76 | 44.5 | Adjuvant (A) | 2015-12-17 | 2015-12-17 | Paclitaxel 7 day | 2 | N | 320003128 | PACLITAXEL |
| 320007156 | 320002720 | null | 57 | null | 2016-01-09 | 2016-06-22 | Bevacizumab | 02 | N | 320003135 | BEVACIZUMAB |
| 320007157 | 320006988 | null | 66.3 | Palliative (P) | 2015-05-30 | 2015-06-20 | Carboplatin AUC 2 - 5 | N | N | 320003217 | CARBOPLATIN |
| 320007158 | 320005217 | 1.73 | 77 | Curative (C) | 2016-09-09 | 2016-09-24 | Carboplatin + Paclitaxel (3 weekly) | 99 | N | 320003344 | CARBOPLATIN + PACLITAXEL |
| 320007159 | 320002765 | 1.64 | null | Palliative (P) | 2016-09-07 | 2016-09-07 | CARBOPLATIN + PACLITAXEL | N | N | 320003856 | CARBOPLATIN + PACLITAXEL |
| 320007160 | 320002776 | 1.74 | 55.85 | Palliative (P) | 2017-05-18 | 2017-05-23 | Carboplatin AUC 6 - 10 | 2 | null | 320004026 | CARBOPLATIN |
| 320007161 | 320002778 | null | 56.4 | Palliative (P) | 2018-10-13 | 2018-11-07 | CARBOPLATIN + PACLITAXEL | N | N | 320004067 | CARBOPLATIN + PACLITAXEL |
| 320007162 | 320005240 | 1.67 | 58.1 | Palliative (P) | null | 2015-11-28 | Carboplatin AUC 6 - 10 | 02 | N | 320004163 | CARBOPLATIN |
| 320007163 | 320002796 | 1.81 | 93.3 | Palliative (P) | 2019-08-10 | 2019-08-16 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 320004218 | CARBOPLATIN + PACLITAXEL |
| 320007164 | 320002804 | 1.8 | 54.6 | Palliative (P) | 2018-10-18 | 2018-10-19 | Paclitaxel 7 day | N | N | 320004279 | PACLITAXEL |
| 320007165 | 320002809 | null | 83.7 | Palliative (P) | 2013-03-08 | 2014-08-19 | Bevacizumab 7.5mg/kg | 02 | N | 320004305 | BEVACIZUMAB |
| 320007166 | 320002812 | 1.83 | 72 | Palliative (P) | 2017-05-02 | 2017-05-03 | Carboplatin AUC 6 - 10 | 02 | N | 320004325 | CARBOPLATIN |
| 320007167 | 320002820 | 1.56 | 85.3 | Palliative (P) | 2016-03-19 | 2016-03-28 | Carboplatin + Paclitaxel (3 weekly) | N | N | 320004533 | CARBOPLATIN + PACLITAXEL |
| 320007168 | 320002832 | 1.6 | 111 | Palliative (P) | 2015-05-04 | 2015-05-11 | Bevacizumab | 2 | N | 320004736 | BEVACIZUMAB |
| 320007169 | 320006995 | 1.59 | 71 | Palliative (P) | 2018-05-04 | 2018-05-20 | PACLITAXEL | 02 | N | 320004794 | PACLITAXEL |
| 320007170 | 320002841 | 1.46 | 77 | 1 | 2016-05-02 | 2016-05-23 | Carboplatin + Paclitaxel (3 weekly) | N | N | 320004871 | CARBOPLATIN + PACLITAXEL |
| 320007171 | 320002854 | 1.55 | null | Adjuvant (A) | 2020-01-08 | 2020-02-16 | Bevacizumab 7.5mg/kg | N | N | 320005101 | BEVACIZUMAB |
| 320007172 | 320002868 | 1.68 | 81.3 | Disease modification (D) | 2014-12-16 | 2015-06-02 | Bevacizumab | 02 | N | 320005382 | BEVACIZUMAB |
| 320007173 | 320005288 | 1.55 | 75.2 | Palliative (P) | 2018-08-16 | 2018-08-26 | CARBOPLATIN | N | N | 320005386 | CARBOPLATIN |
| 320007174 | 320002888 | 1.69 | null | Palliative (P) | 2018-12-17 | 2019-03-13 | CARBOPLATIN + PACLITAXEL | N | null | 320005867 | CARBOPLATIN + PACLITAXEL |